Section Arrow
Quote
PTGX.NASDAQ
- Protagonist Therapeutics
Quotes are at least 15-min delayed:2026/06/02 14:09 EDT
Regular Hours
Last
 94.26
-0.66 (-0.70%)
Day High 
97.71 
Prev. Close
94.92 
1-M High
105.72 
Volume 
484.71K 
Bid
94.1
Ask
94.41
Day Low
93.84 
Open
93.84 
1-M Low
93.5 
Market Cap 
6.10B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 99.83 
20-SMA 100.71 
50-SMA 101.49 
52-W High 107.84 
52-W Low 49.38 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.81/-2.38
Enterprise Value
6.11B
Balance Sheet
Book Value Per Share
10.19
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
46.02M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ADTXAditxt Inc.0.1064-0.0066-5.84%-- 
EVGNEvogene Ltd.0.564101-0.118899-17.41%-- 
FULCFulcrum Therapeutics3.085-3.335-51.95%-- 
AIMAIM ImmunoTech Inc.0.7334-0.1652-18.38%-- 
HRTXHeron Therapeutics0.5-0.3272-39.56%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.